On the other hand, since many tumors express p130Cas, but do not express relevant levels of p140Cap, the existing knowledge on miRNAs acting on p130Cas and p140Cap expression in human tumors, will provide the testable hypothesis on the use of specific anti-miRNAs to enhance an appropriate tumor response in pre-clinical models. The gene discussed is BCAR1; the disease is neoplasm.